Health tech companies made several major funding announcements in October. Here is a list of some of the biggest funding ...

Companies aren't slowing down to ask if AI is ready for mental health; they're racing to build it in. Encoding the same ...

Inovio’s Voceryq will compete with a Precigen product that last year became the first FDA-approved drug for recurrent respiratory papillomatosis, or RRP. While the two immunotherapies carry the same ...

The federal government is testing whether artificial intelligence can help Medicare identify unnecessary medical care, speed ...

Midstream's Series A round was led by Valtruis, and included participation from Andreessen Horowitz (a16z), Foundry and ...

Setara Biosciences’ lead program is a potential treatment for the rare neuromuscular disorder Charcot-Marie-Tooth disease ...

One question on everyone’s mind is what the impact of the midterm elections will be on the US healthcare system in the near ...

For life science employers who offer these benefits should pay particular attention to new state laws and regulations to ...

Gilead Sciences is getting global rights to an experimental PepStar Therapeutics oral peptide designed to inhibit the IL-23 ...

Democratic senators are investigating 10 insurers’ role in the Trump administration’s termination of 760,000 ACA enrollees’ ...

Artiva Biotherapeutics attributed one of the fatalities to a drug used to prepare patients for cell therapy and not to the ...